Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Subscribe

Title Date published
When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai 2024-05-17
Cifu, Mandrola, Prasad - SM crossover 2024-05-10
Patient advocates funded by Pharma 2024-04-17
FDA makes MRD the basis for AA 2024-04-12
Beta Blockers After Heart Attacks Don't Work 2024-04-09
Blood based and Stool DNA colon cancer screening - Two NEJM papers 2024-03-27
Keynote 564 - a flawed study 2024-02-01
CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial 2024-01-27
CAR T causes MDS??? Manni, Goodman, Raj, Prasad 2023-12-28
Timothee and Prasad talk 2023 cancer trials 2023-12-24
Aaron Goodman Prasad ASH UPDATES 2023-12-20
Mandrola and Prasad 2023-12-17
COVID19 Policy: What the US Got Wrong 2023-11-26
Lecture 1 of 4 Curacao - How to Keep Up with Literature 2023-11-24
Advice Pre-Med Students | Lecture at UC Berkeley 2023-11-11
Radiation oncology in GI malignancy - Nina Sanford and Bill Hall 2023-10-31
Hawai Keynote - Coffee and colon cancer & Censoring & More 2023-10-23
Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3 2023-10-19
Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover 2023-10-16
The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3 2023-10-09
1234567891011121314151617181920

Comments about Plenary Session - inactive due to federal service

comments powered by Disqus
Advertisment: